Category: Oncology/Hematology
Global Oncology/Hematology
-
The 2025-2030 World Outlook for Thoracotomy Lung Cancer Surgeries
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs and Diagnostics
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Malignant Mesothelioma
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Silent Cancer Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Oncology Information System Software
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Oncology Information Systems
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032
... reach US$ 45.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.98% during 2024-2032. The market is experiencing steady growth driven by the growing prevalence of cancer due to excessive smoking of tobacco products ... Read More
-
Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
... Research. Enabling early detection and precise identity of cancer kinds makes cancer diagnostics paramount in cutting-edge healthcare. Timely prognosis is pivotal for effective remedies, improving patient consequences, and lowering mortality costs. Modern diagnostic technology, like ... Read More
-
2024 Global Forecast for Lung Cancer Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Lung Cancer Surgery Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Immunotherapy Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Metastatic Breast Cancer Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030
... USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that ... Read More
-
Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Global Forecast to 2029
... to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Global CAR T-Cell Therapy for Multiple Myeloma Market Growth (Status and Outlook) 2024-2030
... 160.4 million in 2023. With growing demand in downstream market, the CAR T-Cell Therapy for Multiple Myeloma is forecast to a readjusted size of US$ 1063 million by 2030 with a CAGR of 31.0% during ... Read More
-
Global Cancer Monoclonal Antibodies Market Growth 2024-2030
... market, the Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ 63370 million by 2030 with a CAGR of 9.5% during review period. The research report highlights the growth potential of the global ... Read More
-
Global Cancer Vaccines Market Growth 2024-2030
... Cancer Vaccines is forecast to a readjusted size of US$ 12280 million by 2030 with a CAGR of 14.9% during review period. The research report highlights the growth potential of the global Cancer Vaccines market. ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market Growth 2024-2030
... downstream market, the Breast Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Acute Myeloid Leukemia Global Market Report 2024
... DC Regimen; AVD Regimen; VCD Regimen4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; ClinicsCovering: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation) Acute Myeloid Leukemia Global Market Report ... Read More
Research Assistance
